Ligand Pharmaceuticals Incorporated (LGNXZ)
OTCMKTS · Delayed Price · Currency is USD
0.0015
0.00 (0.00%)
At close: Aug 29, 2025

Ligand Pharmaceuticals Statistics

Total Valuation

LGNXZ has a market cap or net worth of 3.27 billion. The enterprise value is 3.03 billion.

Market Cap3.27B
Enterprise Value 3.03B

Important Dates

The next estimated earnings date is Friday, November 7, 2025.

Earnings Date Nov 7, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +5.60%
Shares Change (QoQ) +3.83%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 19.16M

Valuation Ratios

PE Ratio n/a
Forward PE 23.52
PS Ratio 17.42
PB Ratio 3.94
P/TBV Ratio 6.85
P/FCF Ratio 60.94
P/OCF Ratio 59.03
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 237.00, with an EV/FCF ratio of 56.48.

EV / Earnings -39.92
EV / Sales 16.14
EV / EBITDA 237.00
EV / EBIT n/a
EV / FCF 56.48

Financial Position

The company has a current ratio of 5.45, with a Debt / Equity ratio of 0.01.

Current Ratio 5.45
Quick Ratio 4.59
Debt / Equity 0.01
Debt / EBITDA 0.27
Debt / FCF 0.11
Interest Coverage -3.92

Financial Efficiency

Return on equity (ROE) is -9.46% and return on invested capital (ROIC) is -1.11%.

Return on Equity (ROE) -9.46%
Return on Assets (ROA) -0.98%
Return on Invested Capital (ROIC) -1.11%
Return on Capital Employed (ROCE) -1.62%
Revenue Per Employee 2.76M
Profits Per Employee -1.12M
Employee Count68
Asset Turnover 0.21
Inventory Turnover 4.67

Taxes

Income Tax -8.63M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is 0.71, so LGNXZ's price volatility has been lower than the market average.

Beta (5Y) 0.71
52-Week Price Change -62.50%
50-Day Moving Average 0.00
200-Day Moving Average 0.00
Relative Strength Index (RSI) 42.20
Average Volume (20 Days) 69,790

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 5.58

Income Statement

In the last 12 months, LGNXZ had revenue of 187.58 million and -75.86 million in losses. Loss per share was -4.00.

Revenue187.58M
Gross Profit 107.79M
Operating Income -14.30M
Pretax Income -84.50M
Net Income -75.86M
EBITDA 19.73M
EBIT -14.30M
Loss Per Share -4.00
Full Income Statement

Balance Sheet

The company has 245.02 million in cash and 5.74 million in debt, giving a net cash position of 239.28 million.

Cash & Cash Equivalents 245.02M
Total Debt 5.74M
Net Cash 239.28M
Net Cash Per Share n/a
Equity (Book Value) 828.53M
Book Value Per Share 42.68
Working Capital 288.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 55.36 million and capital expenditures -1.74 million, giving a free cash flow of 53.62 million.

Operating Cash Flow 55.36M
Capital Expenditures -1.74M
Free Cash Flow 53.62M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 57.46%, with operating and profit margins of -7.62% and -40.44%.

Gross Margin 57.46%
Operating Margin -7.62%
Pretax Margin -45.04%
Profit Margin -40.44%
EBITDA Margin 10.52%
EBIT Margin -7.62%
FCF Margin 28.58%

Dividends & Yields

LGNXZ does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.60%
Shareholder Yield n/a
Earnings Yield -2.32%
FCF Yield 1.64%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

LGNXZ has an Altman Z-Score of 11.36 and a Piotroski F-Score of 3.

Altman Z-Score 11.36
Piotroski F-Score 3